Company / Net Debt per Share
ARS Pharmaceuticals, Inc. Net Debt per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$0.56
FY2025
5-year range
-$0.53 / $0.56
FY2024-FY2025
Trend
+206.6%
vs FY2024
Sector context
#39 of 82
Health Care
What the data says
At $0.56, ARS Pharmaceuticals, Inc.'s net debt per share ranks #44 of 82 in the Health Care sector.
Based on SEC 10-K filings.
0.56 in FY2025.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#44 of 82 in Health CareTop 52% of 82This company $0.56 Sector average $13.70
▼
-95.9% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 206.6% year-over-year.
- Ranks #39 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.56 | +206.6% |
| FY2024 | -$0.53 | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026